Limits...
Biological reconstruction following the resection of malignant bone tumors of the pelvis.

Traub F, Andreou D, Niethard M, Tiedke C, Werner M, Tunn PU - Sarcoma (2013)

Bottom Line: Two- and five-year disease-specific survival rates of all patients were 86.1% and 57.7%, respectively.The mean functional MSTS score was 16.5 (~55%) for all patients.Conclusion.

View Article: PubMed Central - PubMed

Affiliation: Department of Orthopedic Oncology, Sarcoma Center Berlin-Brandenburg, HELIOS Klinikum Berlin-Buch, Schwanebecker Chaussee 50, 13125 Berlin, Germany.

ABSTRACT
Background. Surgical treatment of malignant pelvic bone tumors can be very challenging. The objective of this retrospective study was to evaluate the oncological as well as the clinical and functional outcome after limb salvage surgery and biological reconstruction. Methods. The files of 27 patients with malignant pelvic bone tumors, who underwent surgical resection at our department between 2000 and 2011, were retrospectively analyzed (9 Ewing's sarcoma, 8 chondrosarcoma, 4 osteosarcoma, 1 synovial sarcoma, 1 malignant fibrous histiocytoma, and 4 carcinoma metastases). Results. After internal hemipelvectomy reconstruction was performed by hip transposition (n = 16), using autologous nonvascularised fibular graft (n = 5) or autologous iliac crest bone graft (n = 2). In one patient a proximal femor prothetis and in three patients a total hip prosthesis was implanted at the time of resection. The median follow-up was 33 months. Two- and five-year disease-specific survival rates of all patients were 86.1% and 57.7%, respectively. The mean functional MSTS score was 16.5 (~55%) for all patients. Conclusion. On the basis of the oncological as well as the clinical and functional outcome, biological reconstruction after internal hemipelvectomy seems to be a reliable technique for treating patients with a malignant pelvic bone tumor.

No MeSH data available.


Related in: MedlinePlus

A Classification of pelvic resection [5].
© Copyright Policy - open-access
Related In: Results  -  Collection


getmorefigures.php?uid=PMC3649758&req=5

fig1: A Classification of pelvic resection [5].

Mentions: The treatment of malignant bone tumors involving the pelvis is a great challenge to the orthopaedic surgeon in terms of local control owing to the complexity of pelvic anatomy, which increases the difficulty of resection and reconstruction. First attempts to excise malignant bone tumors of the pelvis were reported by Enneking in 1966 [3] and Steel in 1978 [4]. Resection of the tumor can be performed either by internal or external hemipelvectomy. Pelvic resections have been classified by the Musculoskeletal Tumor Society into 4 resection types: type I (iliac), type II (periacetabular), type III (os pubis, ischii), and type IV (sacrum) [5–8]; see also Figure 1.


Biological reconstruction following the resection of malignant bone tumors of the pelvis.

Traub F, Andreou D, Niethard M, Tiedke C, Werner M, Tunn PU - Sarcoma (2013)

A Classification of pelvic resection [5].
© Copyright Policy - open-access
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC3649758&req=5

fig1: A Classification of pelvic resection [5].
Mentions: The treatment of malignant bone tumors involving the pelvis is a great challenge to the orthopaedic surgeon in terms of local control owing to the complexity of pelvic anatomy, which increases the difficulty of resection and reconstruction. First attempts to excise malignant bone tumors of the pelvis were reported by Enneking in 1966 [3] and Steel in 1978 [4]. Resection of the tumor can be performed either by internal or external hemipelvectomy. Pelvic resections have been classified by the Musculoskeletal Tumor Society into 4 resection types: type I (iliac), type II (periacetabular), type III (os pubis, ischii), and type IV (sacrum) [5–8]; see also Figure 1.

Bottom Line: Two- and five-year disease-specific survival rates of all patients were 86.1% and 57.7%, respectively.The mean functional MSTS score was 16.5 (~55%) for all patients.Conclusion.

View Article: PubMed Central - PubMed

Affiliation: Department of Orthopedic Oncology, Sarcoma Center Berlin-Brandenburg, HELIOS Klinikum Berlin-Buch, Schwanebecker Chaussee 50, 13125 Berlin, Germany.

ABSTRACT
Background. Surgical treatment of malignant pelvic bone tumors can be very challenging. The objective of this retrospective study was to evaluate the oncological as well as the clinical and functional outcome after limb salvage surgery and biological reconstruction. Methods. The files of 27 patients with malignant pelvic bone tumors, who underwent surgical resection at our department between 2000 and 2011, were retrospectively analyzed (9 Ewing's sarcoma, 8 chondrosarcoma, 4 osteosarcoma, 1 synovial sarcoma, 1 malignant fibrous histiocytoma, and 4 carcinoma metastases). Results. After internal hemipelvectomy reconstruction was performed by hip transposition (n = 16), using autologous nonvascularised fibular graft (n = 5) or autologous iliac crest bone graft (n = 2). In one patient a proximal femor prothetis and in three patients a total hip prosthesis was implanted at the time of resection. The median follow-up was 33 months. Two- and five-year disease-specific survival rates of all patients were 86.1% and 57.7%, respectively. The mean functional MSTS score was 16.5 (~55%) for all patients. Conclusion. On the basis of the oncological as well as the clinical and functional outcome, biological reconstruction after internal hemipelvectomy seems to be a reliable technique for treating patients with a malignant pelvic bone tumor.

No MeSH data available.


Related in: MedlinePlus